Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — DHEAS

Title: Understanding CardioMetabolic Risk – A Silent Threat We Can’t Ignore The rise in cardiovascular disease (CVD), obesity, and type 2 diabetes (DM2) is one of the most pressing health concerns of our time. CVD remains the leading cause of death for both men and women in the United States. Alarmingly, obesity and insulin resistance—precursors to DM2—significantly increase the risk of developing CVD. Yet, these conditions are largely preventable with early detection and lifestyle changes. So, how can we spot the danger before it's too late? What is CardioMetabolic Risk? Cardiometabolic risk refers to a cluster of modifiable risk factors...

Fertility Mapping: Navigating Fertility with PCOS and Insulin Resistance (Part II)By Dr. Alison McAllister Polycystic Ovary Syndrome (PCOS) is a complex, multifactorial condition influenced by disruptions in hormone receptors, metabolism, neurotransmitter function, and nutrient balance. As a lifelong disorder, PCOS is a leading contributor to infertility, weight gain, and an increased risk for cardiometabolic issues. In this blog post, we dive deeper into laboratory testing, helping healthcare providers understand which tests are critical for women suspected of having PCOS. Lab Testing for PCOS PCOS is most commonly diagnosed through the Rotterdam Criteria, a diagnostic framework that considers various indicators, including...

When a patient with PCOS or weight issues is told “your blood sugar is normal,” the story is far from over. In this clinical article, Dr. Alison McAllister of ZRT Laboratory explains why insulin — not glucose — is the primary driver of PCOS symptoms, weight gain, testosterone and DHEAS excess, and cortisol dysfunction. Understanding the progression from insulin resistance to hyperinsulinemia to type 2 diabetes is essential for identifying and treating PCOS at the earliest possible stage.